Conversely, TLR7 knockout or TLR7 antagonist treatment restores Tregs proportions, mitigates intrahepatic inflammation, and reduces hepatic steatosis (110) (Figure 3b). The gene discussed is TLR7; the disease is Hepatic steatosis.